Bladder cancer (BC) is a common and serious type of cancer that ranks among the top ten
most prevalent malignancies worldwide. Due to the high occurrence rate of BC, the …

N 6-methyladenosine (m 6 A) is the most abundant modification in eukaryotic cells, and it
regulates RNA transcription, processing, splicing, degradation, and translation. Long non …

Background Bladder cancer (BLCA) is one of the deadliest diseases, with over 550,000 new
cases and 170,000 deaths globally every year. Cuproptosis is a copper-triggered …

Long non-coding RNAs (lncRNAs) are emerging as crucial regulators of gene expression
and physiological processes. LncRNAs are a class of ncRNAs of 200 nucleotides in length …

Abnormal m6A methylation plays a significant role in cancer progression. Increasingly,
researchers have focused on developing lncRNA signatures to evaluate the prognosis of …

The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …

Despite the recent scientific advances made in cancer diagnostics and therapeutics, cancer
still remains the second leading cause of death worldwide. Thus, there is a need to identify …

Bladder cancer is the ninth most diagnosed cancer in the world. This study aims to
investigate the role and mechanisms of the taurine-upregulated gene 1 (TUG1)/miR-140 …

Long noncoding RNAs (lncRNAs) play crucial regulatory roles in fundamental biological
processes, and deregulations of lncRNAs have been linked to numerous human diseases …

The types of urothelial carcinoma (UC) include urothelial bladder cancer and upper tract
urothelial carcinoma. Current diagnostic techniques cannot meet the needs of patients …